<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34833495</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>11</Month>
        <Day>30</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>11</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1648-9144</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>57</Volume>
            <Issue>11</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Nov</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Medicina (Kaunas, Lithuania)</Title>
          <ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Fetal Surveillance in Pregnancies with Myasthenia Gravis.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">1277</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/medicina57111277</ELocationID>
        <Abstract>
          <AbstractText>Myasthenia gravis (MG) is an autoimmune condition, that commonly impacts adult women of reproductive age. Myasthenia gravis in pregnancy is rare, but the incidence is higher in different geographical areas. Pregnancies in mothers with MG can have an unfortunate outcome. Acetylcholine receptor antibodies may pass into the fetal circulation and can affect the fetal neuromuscular junction, generating transient MG or even fetal arthrogryposis. The 2016 and 2021 International Consensus Guidance for Management of Myasthenia Gravis issued by Myasthenia Gravis Foundation of America is lacking in recommendation for fetal surveillance for pregnancies in women with MG. The aim of this paper is to highlight fetal and neonatal complications in mothers with MG and to offer antenatal care insights. Close maternal and pregnancy monitoring can improve pregnancy outcome. Patients with MG should be encouraged to conceive, to avoid triggers for exacerbations of the disease during pregnancy and a multidisciplinary team should be established to ensure the optimal support and therapy.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cimpoca-Raptis</LastName>
            <ForeName>Brîndușa Ana</ForeName>
            <Initials>BA</Initials>
            <Identifier Source="ORCID">0000-0002-9745-9891</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Filantropia Clinical Hospital, 011132 Bucharest, Romania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ciobanu</LastName>
            <ForeName>Anca Marina</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Filantropia Clinical Hospital, 011132 Bucharest, Romania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gica</LastName>
            <ForeName>Nicolae</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0002-8425-6307</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Filantropia Clinical Hospital, 011132 Bucharest, Romania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peltecu</LastName>
            <ForeName>Gheorghe</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Filantropia Clinical Hospital, 011132 Bucharest, Romania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mitrea</LastName>
            <ForeName>Dan</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroaxis, Neurology Clinic, 011302 Bucharest, Romania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Panaitescu</LastName>
            <ForeName>Anca Maria</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Filantropia Clinical Hospital, 011132 Bucharest, Romania.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Medicina (Kaunas)</MedlineTA>
        <NlmUniqueID>9425208</NlmUniqueID>
        <ISSNLinking>1010-660X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011950">Receptors, Cholinergic</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009035" MajorTopicYN="N">Mothers</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009157" MajorTopicYN="Y">Myasthenia Gravis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011295" MajorTopicYN="Y">Prenatal Care</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011950" MajorTopicYN="N">Receptors, Cholinergic</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">arthrogryposis</Keyword>
        <Keyword MajorTopicYN="N">myasthenia gravis</Keyword>
        <Keyword MajorTopicYN="N">pregnancy</Keyword>
        <Keyword MajorTopicYN="N">transient neonatal myasthenia gravis</Keyword>
      </KeywordList>
      <CoiStatement>No conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>27</Day>
          <Hour>1</Hour>
          <Minute>21</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34833495</ArticleId>
        <ArticleId IdType="pmc">PMC8624595</ArticleId>
        <ArticleId IdType="doi">10.3390/medicina57111277</ArticleId>
        <ArticleId IdType="pii">medicina57111277</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Gilhus N.E. Myasthenia gravis. N. Engl. J. Med. 2016;375:2570–2581. doi: 10.1056/NEJMra1602678.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra1602678</ArticleId>
            <ArticleId IdType="pubmed">28029925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frykman H., Kumar P., Oger J. Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies. Front. Neurol. 2020;11:596621. doi: 10.3389/fneur.2020.596621.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fneur.2020.596621</ArticleId>
            <ArticleId IdType="pmc">PMC7755715</ArticleId>
            <ArticleId IdType="pubmed">33362698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hamel J., Ciafaloni E. An Update: Myasthenia Gravis and Pregnancy. Neurol. Clin. 2018;36:355–365. doi: 10.1016/j.ncl.2018.01.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ncl.2018.01.005</ArticleId>
            <ArticleId IdType="pubmed">29655454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGrogan A., Sneddon S., De Vries C.S. The incidence of myasthenia gravis: A systematic literature review. Neuroepidemiology. 2010;34:171–183. doi: 10.1159/000279334.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000279334</ArticleId>
            <ArticleId IdType="pubmed">20130418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ciobanu A.M., Dumitru A.E., Gica N., Botezatu R., Peltecu G., Panaitescu A.M. Benefits and Risks of IgG Transplacental Transfer. Diagnostics. 2020;10:583.  doi: 10.3390/diagnostics10080583.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/diagnostics10080583</ArticleId>
            <ArticleId IdType="pmc">PMC7459488</ArticleId>
            <ArticleId IdType="pubmed">32806663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hesselmans L.F.G.M., Jennekens F.G.I., Oord C.J.M.V.D., Veldman H., Vincent A. Development of innervation of skeletal muscle fibers in man: Relation to acetylcholine receptors. Anat. Rec. 1993;236:553–562. doi: 10.1002/ar.1092360315.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ar.1092360315</ArticleId>
            <ArticleId IdType="pubmed">8363059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cetin H., Beeson D., Vincent A., Webster R. The Structure, Function, and Physiology of the Fetal and Adult Acetylcholine Receptor in Muscle. Front. Mol. Neurosci. 2020;13:581097. doi: 10.3389/fnmol.2020.581097.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnmol.2020.581097</ArticleId>
            <ArticleId IdType="pmc">PMC7506097</ArticleId>
            <ArticleId IdType="pubmed">33013323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vernet-der Garabedian B., Lacokova M., Eymard B., Morel E., Faltin M., Zajac J., Sadovsky O., Dommergues M., Tripon P., Bach J.F. Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor. J. Clin. Investig. 1994;94:555–559. doi: 10.1172/JCI117369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI117369</ArticleId>
            <ArticleId IdType="pmc">PMC296130</ArticleId>
            <ArticleId IdType="pubmed">8040310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gilhus N.E., Hong Y. Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence. Eur. J. Neurol. 2018;25:1402–1409. doi: 10.1111/ene.13788.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ene.13788</ArticleId>
            <ArticleId IdType="pubmed">30133097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanders D.B., Wolfe G.I., Benatar M., Evoli A., Gilhus N.E., Illa I., Kuntz N., Massey J.M., Melms A., Murai H., et al.  International consensus guidance for management of myasthenia gravis: Executive summary. Neurology. 2016;26:419–425. doi: 10.1212/WNL.0000000000002790.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000002790</ArticleId>
            <ArticleId IdType="pmc">PMC4977114</ArticleId>
            <ArticleId IdType="pubmed">27358333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Narayanaswami P., Sanders D.B., Wolfe G., Benatar M., Cea G., Evoli A., Gilhus N.E., Illa I., Kuntz N.L., Massey J., et al.  International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update. Neurology. 2021;96:114–122. doi: 10.1212/WNL.0000000000011124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000011124</ArticleId>
            <ArticleId IdType="pmc">PMC7884987</ArticleId>
            <ArticleId IdType="pubmed">33144515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gilhus N.E. Myasthenia Gravis Can Have Consequences for Pregnancy and The Developing Child. Front. Neurol. 2020;11:554. doi: 10.3389/fneur.2020.00554.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fneur.2020.00554</ArticleId>
            <ArticleId IdType="pmc">PMC7304249</ArticleId>
            <ArticleId IdType="pubmed">32595594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Girotra T., Baki N., Grover K. Rituximab for Refractory Myasthenia Gravis in a Pregnant Patient (P2.165) Neurology. 2016;86((Suppl. 16))</Citation>
        </Reference>
        <Reference>
          <Citation>Leroy C., Rigot J.-M., Leroy M., Decanter C., Le Mapihan K., Parent A.-S., Le Guillou A.-C., Yakoub-Agha I., Dharancy S., Noel C., et al.  Immunosuppressive drugs and fertility. Orphanet J. Rare Dis. 2015;10:136. doi: 10.1186/s13023-015-0332-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13023-015-0332-8</ArticleId>
            <ArticleId IdType="pmc">PMC4618138</ArticleId>
            <ArticleId IdType="pubmed">26490561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Norwood F., Dhanjal M., Hill M., James N., Jungbluth H., Kyle P., O’Sullivan G., Palace J., Robb S., Williamson C., et al.  Myasthenia in pregnancy: Best practice guidelines from a U.K. multispecialty working group. J. Neurol. Neurosurg. Psychiatry. 2014;85:538–543. doi: 10.1136/jnnp-2013-305572.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp-2013-305572</ArticleId>
            <ArticleId IdType="pubmed">23757420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoff J.M., Daltveit A.K., Gilhus N.E. Myasthenia gravis in pregnancy and birth: Identifying risk factors, optimising care. Eur. J. Neurol. 2007;14:38–43. doi: 10.1111/j.1468-1331.2006.01538.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1468-1331.2006.01538.x</ArticleId>
            <ArticleId IdType="pubmed">17222111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfe G.I., Kaminski H.J., Aban I.B., Minisman G., Kuo H.C., Marx A., Ströbel P., Mazia C., Oger J., Cea G., et al.  Randomized trial of thymectomy in myasthenia gravis. N. Engl. J. Med. 2016;375:511–522. doi: 10.1056/NEJMoa1602489.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1602489</ArticleId>
            <ArticleId IdType="pmc">PMC5189669</ArticleId>
            <ArticleId IdType="pubmed">27509100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eidex R.B. History of thymoma and yellow fever vaccination. Lancet. 2004;364:936. doi: 10.1016/S0140-6736(04)17017-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(04)17017-7</ArticleId>
            <ArticleId IdType="pubmed">15364184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrero S., Pretta S., Nicoletti A., Petrera P., Ragni N. Myasthenia gravis: Management issues during pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2005;121:129–138. doi: 10.1016/j.ejogrb.2005.01.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejogrb.2005.01.002</ArticleId>
            <ArticleId IdType="pubmed">16054951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Plauché W.C. Myasthenia gravis in mothers and their newborns. Clin. Obstet. Gynecol. 1991;34:82. doi: 10.1097/00003081-199103000-00012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00003081-199103000-00012</ArticleId>
            <ArticleId IdType="pubmed">2025979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bershad E.M., Feen E.S., Suárez J.I. Myasthenia gravis crisis. South Med. J. 2008;101:63–69. doi: 10.1097/SMJ.0b013e31815d4398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/SMJ.0b013e31815d4398</ArticleId>
            <ArticleId IdType="pubmed">18176295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirke P.N., Daly L.E., Elwood J.H. A randomised trial of low-dose folic acid to prevent neural tube defects. Arch. Dis. Child. 1992;67:1442–1446. doi: 10.1136/adc.67.12.1442.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/adc.67.12.1442</ArticleId>
            <ArticleId IdType="pmc">PMC1793975</ArticleId>
            <ArticleId IdType="pubmed">1489222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kachikis A., Oler E., Shree R., Adams Waldorf K., Hitti J., Eckert L.O.  Measles and the MMR Vaccine: Recommendations around Pregnancy, Including the Periconception and Postpartum Periods. Obstetric Consensus Statement; University of Washington; Seattle, WA, USA: 2019. </Citation>
        </Reference>
        <Reference>
          <Citation> [(accessed on 29 October 2021)]; Available online:  https://www.cdc.gov/vaccines/pregnancy/index.html.</Citation>
        </Reference>
        <Reference>
          <Citation>Robinson H.P., Fleming J.E.E. A critical evaluation of sonar “crown-rump length” measurements. Br. J. Obstet. Gynaecol. 1975;82:702–710. doi: 10.1111/j.1471-0528.1975.tb00710.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1471-0528.1975.tb00710.x</ArticleId>
            <ArticleId IdType="pubmed">1182090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stafford I.P., Dildy G.A. Myasthenia gravis and pregnancy. Clin. Obstet. Gynecol. 2005;48:48–56. doi: 10.1097/01.grf.0000153206.85996.07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.grf.0000153206.85996.07</ArticleId>
            <ArticleId IdType="pubmed">15725856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fraser F.C., Sajoo A. Teratogenic potential of corticosteroids in humans. Teratology. 1995;51:45–46. doi: 10.1002/tera.1420510107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/tera.1420510107</ArticleId>
            <ArticleId IdType="pubmed">7597656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodríguez-Pinilla E., Martínez-Frías M.L. Corticosteroids during pregnancy and oral clefts: A case-control study. Teratology. 1998;58:2–5. doi: 10.1002/(SICI)1096-9926(199807)58:1&lt;2::AID-TERA2&gt;3.0.CO;2-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1096-9926(199807)58:1&lt;2::AID-TERA2&gt;3.0.CO;2-4</ArticleId>
            <ArticleId IdType="pubmed">9699238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vu T., Harvey B., Suresh N., Farias J., Gooch C. Eculizumab during Pregnancy in a Patient with Treatment-Refractory Myasthenia Gravis: A Case Report. Case Rep. Neurol. 2021;13:65–72. doi: 10.1159/000511957.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000511957</ArticleId>
            <ArticleId IdType="pmc">PMC7923701</ArticleId>
            <ArticleId IdType="pubmed">33708096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gil M.M., Galeva S., Nicolaides K.N. Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: Update of The Fetal Medicine Foundation results and meta-analysis. Ultrasound Obstet. Gynecol. 2019;53:734–742.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31165549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rolnik D.L., Wright D., Poon L.L., Syngelaki A.A., O’Gorman N.N., Matallana C.C.D.P., Akolekar R.R., Cicero S.S., Janga D.D., Singh M.M., et al.  ASPRE trial: Performance of screening for preterm pre-eclampsia. Ultrasound Obstet. Gynecol. 2017;50:492–495. doi: 10.1002/uog.18816.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/uog.18816</ArticleId>
            <ArticleId IdType="pubmed">28741785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polizzi A., Huson S.M., Vincent A. Teratogen update: Maternal myasthenia gravis as a cause of congenital arthrogryposis. Teratology. 2000;62:332–341. doi: 10.1002/1096-9926(200011)62:5&lt;332::AID-TERA7&gt;3.0.CO;2-E.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/1096-9926(200011)62:5&lt;332::AID-TERA7&gt;3.0.CO;2-E</ArticleId>
            <ArticleId IdType="pubmed">11029151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hall J.G. Arthrogryposis multiplex congenita: Etiology, genetics, classification, diagnostic approach, and general aspects. J. Pediatr. Orthop. B. 1997;6:159–166. doi: 10.1097/01202412-199707000-00002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01202412-199707000-00002</ArticleId>
            <ArticleId IdType="pubmed">9260643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vincent A. Aetiological factors in development of myasthenia gravis. Adv. Neuroimmunol. 1994;4:355–371. doi: 10.1016/0960-5428(94)00041-L.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0960-5428(94)00041-L</ArticleId>
            <ArticleId IdType="pubmed">7719616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nicolaides K.N. Screening for fetal chromosomal abnormalities: Need to change the rules. Ultrasound Obstet. Gynecol. 1994;4:353–354. doi: 10.1046/j.1469-0705.1994.04050353.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1469-0705.1994.04050353.x</ArticleId>
            <ArticleId IdType="pubmed">12797139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Veduta A., Vayna A.M., Duta S., Panaitescu A., Popescu F., Bari M., Peltecu G., Nedelea F. The first trimester combined test for aneuploidies—A single center experience. J. Matern. Neonatal Med. 2018;31:2091–2096. doi: 10.1080/14767058.2017.1336220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/14767058.2017.1336220</ArticleId>
            <ArticleId IdType="pubmed">28553771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vincent A., McConville J., Farrugia M.E., Bowen J., Plested P., Tang T., Evoli A., Matthews I., Sims G., Dalton P., et al.  Antibodies in myasthenia gravis and related disorders. Ann. N. Y. Acad. Sci. 2003;998:324–335. doi: 10.1196/annals.1254.036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1196/annals.1254.036</ArticleId>
            <ArticleId IdType="pubmed">14592891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Almeida C., Coutinho E., Moreira D., Santos E., Aguiar J. Myasthenia gravis and pregnancy: Anaesthetic management—A series of cases. Eur. J. Anaesthesiol. 2010;11:985–990. doi: 10.1097/EJA.0b013e32833e263f.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/EJA.0b013e32833e263f</ArticleId>
            <ArticleId IdType="pubmed">20733499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee S., Webb C., Armstrong S. Myasthenia Gravis and Pregnancy.  [(accessed on 29 October 2021)];ATOTW. 2021 :443. Available online:  https://resources.wfsahq.org/atotw/myasthenia-gravis-and-pregnancy/</Citation>
        </Reference>
        <Reference>
          <Citation>Batocchi A.P., Majolini L., Evoli A., Lino M.M., Minisci C., Tonali P. Course and treatment of myasthenia gravis during pregnancy. Neurology. 1999;52:447–452. doi: 10.1212/WNL.52.3.447.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.52.3.447</ArticleId>
            <ArticleId IdType="pubmed">10025772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verspyck E., Mandelbrot L., Dommergues M., Huon C., Woimant F., Baumann C., Garabedian B.V.D. Myasthenia gravis with polyhydramnios in the fetus of an asymptomatic mother. Prenat. Diagn. 1993;13:539–542. doi: 10.1002/pd.1970130618.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pd.1970130618</ArticleId>
            <ArticleId IdType="pubmed">8372081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panaitescu A., Nicolaides K. Maternal autoimmune disorders and fetal defects. J. Matern.-Fetal Neonatal Med. 2018;31:1798–1806. doi: 10.1080/14767058.2017.1326904.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/14767058.2017.1326904</ArticleId>
            <ArticleId IdType="pubmed">28627279</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
